HCW Biologics Inc.

HCWB

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001828673

SEC filings (opens in a new tab)

In the last 90 days, HCW Biologics Inc. insiders filed 3 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $515.7K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding HCW Biologics Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of HCWB: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	13	14	+1
Shares	1.00M	1.01M	+14.4K (+1.4%)
Value	$2.17M	$1.93M	−$239.1K (−11.0%)

New holders (2)

Institutions that held HCW Biologics Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to HCWB in Q3 2023
Institution	Shares	Value	% of portfolio
UBS Group AG	212	$403	0.00%
JPMorgan Chase & Co	22	$42	0.00%

Sold out (1)

Institutions that held HCW Biologics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of HCWB in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Royal Bank of Canada	141	$0